nedaplatin has been researched along with Body Weight in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, S; Itoh, F; Koshida, H; Maruyama, T; Nakamura, M; Uehara, T; Watanabe, H; Yamate, J | 1 |
| Maruyama, T; Masuda, A; Nakamura, M; Torii, M; Tsuchiya, N; Uehara, T; Yamate, J | 1 |
| Daikatsu, K; Ikeuchi, I; Maekawa, R; Sugita, K; Uchida, N; Wada, T; Yamada, H; Yoshida, H; Yoshioka, T | 1 |
| Maekawa, R; Uchida, N; Yamada, H; Yoshioka, T | 1 |
4 other study(ies) available for nedaplatin and Body Weight
| Article | Year |
|---|---|
Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats.
Topics: Animals; Antineoplastic Agents; Body Weight; Cisplatin; Female; In Vitro Techniques; Injections, Intravenous; Kidney; Kidney Diseases; Kidney Function Tests; Kidney Tubules, Collecting; Longevity; Lysosomes; Male; Organ Size; Organoplatinum Compounds; Proteinuria; Rats; Rats, Sprague-Dawley | 2005 |
Time course of the change and amelioration of nedaplatin-induced nephrotoxicity in rats.
Topics: Animals; Antineoplastic Agents; Apoptosis; Body Water; Body Weight; Dose-Response Relationship, Drug; Drinking; Eating; Fluid Therapy; Injections, Intravenous; Kidney; Kidney Diseases; Kidney Function Tests; Kidney Tubules; Longevity; Male; Organoplatinum Compounds; Rats; Time Factors; Water-Electrolyte Balance | 2008 |
Combination chemotherapy with nedaplatin and cyclophosphamide in human ovarian cancer model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Body Weight; Cell Division; Cisplatin; Cyclophosphamide; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Organoplatinum Compounds; Ovarian Neoplasms; Survival Rate; Tumor Cells, Cultured | 1999 |
Sequence-dependent antitumor efficacy of combination chemotherapy with nedaplatin, a newly developed platinum, and paclitaxel.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carboplatin; Carcinoma, Lewis Lung; Cisplatin; Female; Liver; Lung Neoplasms; Mice; Mice, Inbred C57BL; Organoplatinum Compounds; Paclitaxel; Time Factors | 2001 |